DONADELLI, Massimo
 Distribuzione geografica
Continente #
NA - Nord America 4.883
EU - Europa 4.384
AS - Asia 3.058
SA - Sud America 463
AF - Africa 45
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.847
Nazione #
US - Stati Uniti d'America 4.781
GB - Regno Unito 1.211
CN - Cina 1.133
SG - Singapore 1.098
RU - Federazione Russa 977
IT - Italia 600
BR - Brasile 405
HK - Hong Kong 327
DE - Germania 319
FR - Francia 297
SE - Svezia 276
IE - Irlanda 237
FI - Finlandia 204
VN - Vietnam 142
KR - Corea 90
UA - Ucraina 66
CA - Canada 53
ID - Indonesia 52
TR - Turchia 50
NL - Olanda 41
MX - Messico 39
BE - Belgio 38
JP - Giappone 38
ES - Italia 30
IN - India 29
PL - Polonia 27
BD - Bangladesh 24
AR - Argentina 23
AT - Austria 23
IR - Iran 14
ZA - Sudafrica 12
SA - Arabia Saudita 11
TG - Togo 9
AU - Australia 8
IQ - Iraq 8
EC - Ecuador 7
CO - Colombia 6
LT - Lituania 6
PK - Pakistan 6
CL - Cile 5
IL - Israele 5
MY - Malesia 5
UZ - Uzbekistan 5
VE - Venezuela 5
DZ - Algeria 4
MA - Marocco 4
PE - Perù 4
RO - Romania 4
TN - Tunisia 4
BG - Bulgaria 3
BO - Bolivia 3
CH - Svizzera 3
MM - Myanmar 3
PY - Paraguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BA - Bosnia-Erzegovina 2
CZ - Repubblica Ceca 2
DK - Danimarca 2
EE - Estonia 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
NO - Norvegia 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
TZ - Tanzania 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
AZ - Azerbaigian 1
BB - Barbados 1
BY - Bielorussia 1
CR - Costa Rica 1
EG - Egitto 1
EU - Europa 1
GA - Gabon 1
GD - Grenada 1
GE - Georgia 1
GP - Guadalupe 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
KH - Cambogia 1
KI - Kiribati 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
ML - Mali 1
NC - Nuova Caledonia 1
NE - Niger 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
Totale 12.839
Città #
Southend 1.082
Dallas 677
Chandler 676
Singapore 454
Jacksonville 361
Woodbridge 328
Hong Kong 326
Ann Arbor 302
Ashburn 266
Moscow 255
Dublin 235
Verona 231
Beijing 223
New York 171
Houston 147
Munich 99
Lawrence 93
Princeton 93
Wilmington 89
Los Angeles 82
Nanjing 75
Jinan 70
Redmond 70
The Dalles 69
Shenyang 62
Helsinki 52
Phoenix 51
Columbus 48
Hebei 48
Tianjin 48
Dong Ket 45
Jakarta 45
Buffalo 44
Redondo Beach 44
Milan 37
Changsha 36
Brussels 35
Redwood City 34
São Paulo 34
Seoul 33
Sindelfingen 33
Turku 33
Tokyo 32
Venice 32
Zhengzhou 31
Haikou 30
Nanchang 28
London 26
Council Bluffs 25
Düsseldorf 24
Ho Chi Minh City 24
Ningbo 23
Boardman 22
Guangzhou 22
Hangzhou 21
Norwalk 21
Santa Clara 21
Jiaxing 20
Seattle 20
Brooklyn 18
Lappeenranta 18
Frankfurt am Main 17
Kent 17
Rio de Janeiro 17
Toronto 17
Taizhou 16
Warsaw 16
Mexico City 15
Montreal 15
San Francisco 14
Boston 13
Chicago 13
Hanoi 13
Nuremberg 13
Stockholm 13
Taiyuan 13
Augusta 12
Caserta 12
Madrid 12
Vienna 11
Washington 11
Fuzhou 10
Manchester 10
Poplar 10
Atlanta 9
Auburn Hills 9
Denver 9
Falkenstein 9
Falls Church 9
Lomé 9
Bologna 8
Johannesburg 8
Querétaro 8
Curitiba 7
Dearborn 7
Lanzhou 7
Mestre 7
Secaucus 7
Shanghai 7
Amsterdam 6
Totale 8.130
Nome #
Gemcitabine/cannabinoid combination triggers autophagy in pancreatic cancer cells through a ROS-mediated mechanism 274
Biopsychosocial model of resilience in young adults with multiple sclerosis (BPS-ARMS): an observational study protocol exploring psychological reactions early after diagnosis 232
Gemcitabine response in pancreatic adenocarcinoma cells is synergistically enhanced by dithiocarbamate derivatives 226
Expression of the antiapoptotic protein BAG3 is a feature of pancreatic adenocarcinoma and its overexpression is associated with poorer survival 192
Cytotoxicity of Polyspermine-Ribonuclease A and Polyspermine-Dimeric Ribonuclease A 184
ISOLATION AND DRUG SENSITIVITY OF CANCER STEM CELLS OBTAINED FROM PANCREATIC ADENOCARCINOMA CELL LINES 184
Autophagy induced by p53-reactivating molecules protects pancreatic cancer cells from apoptosis. 184
Gene expression profiling after treatment with the histone deacetylase inhibitor trichostatin A reveals altered expression of both pro- and anti-apoptotic genes in pancreatic adenocarcinoma cells. 179
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 179
Activation of the Interleukin-6 promoter by a dominant negative mutant of c-Jun 178
Role of mitochondrial uncoupling protein-2 in cancer cell resistance to gemcitabine 177
Bone marrow stromal cells and the upregulation of interleukin-8 production in human T-cell acute lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-kappaB and JNK/AP-1 pathways 174
CXCL12-MEDIATED NF-KAPPAB AND C-JUN ACTIVATION REGULATES INTERLEUKIN 8 PRODUCTION IN HUMAN T-LYMPHOBLASTIC LEUKEMIA 170
Intracellular zinc increase inhibits p53(-/-) pancreatic adenocarcinoma cell growth by ROS/AIF-mediated apoptosis 166
UCP2 inhibition triggers ROS-dependent nuclear translocation of GAPDH and autophagic cell death in pancreatic adenocarcinoma cells 163
Bovine seminal ribonuclease triggers Beclin1-mediated autophagic cell death in pancreatic cancer cells 161
Pancreatic endocrine tumours, a proteomic investigation of the trichostatin-A antitumoral effect 159
Mutant p53 proteins counteract autophagic mechanism sensitizing cancer cells to mTOR inhibition 159
REDOX SIGNALING HYPERSENSITIVITY DISTINGUISHES CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS WITH FAVORABLE PROGNOSIS 155
Regulation of miR-23b expression and its dual role on ROS production and tumour development 154
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells 153
Hyaluronic acid-coated liposomes for active targeting of gemcitabine 153
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists 151
HUMAN T-LYMPHOBLASTIC LEUKAEMIA CELLS PRODUCE IL-8 IN RESPONSE TOCXCL12 SECRETED BY NORMAL BONE MARROW STROMA 151
Antioxidant Mechanisms and ROS-Related MicroRNAs in Cancer Stem Cells 149
Cell communication and signaling: how to turn bad language into positive one 148
Proteomics in pancreatic cancer research. 145
Gain-of-function mutant p53 enhances mitochondrial ROS through the inhibition of PGC-1α/UCP2 axis in cancer cells 144
Low catalase expression confers redox hypersensitivity and identifies an indolent clinical behavior in CLL 142
The rs1001179 SNP and CpG methylation regulate catalase expression in chronic lymphocytic leukemia 141
MeCP2/H3meK9 are involved in IL-6 gene silencing in pancreatic adenocarcinoma cell lines 141
Onconase induces autophagy sensitizing pancreatic cancer cells to gemcitabine and activates Akt/mTOR pathway in a ROS-dependent manner 140
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 135
Increase of RNase A N-terminus Polarity or C-terminus Apolarity Changes the Two Domains' Propensity To Swap and Form the Two Dimeric Conformers of the Protein 132
Synergistic inhibition of pancreatic adenocarcinoma cell growth by trichostatin A and gemcitabine 132
Identification of a candidate alternative promoter region of the human Bcl2L11 (Bim) gene 132
Double Domain Swapping in Bovine Seminal RNase: Formation of Distinct N- and C-swapped Tetramers and Multimers with Increasing Biological Activities 132
Browsing the oldest antioxidant enzyme: catalase and its multiple regulation in cancer 132
A comparison study on RNase A oligomerization induced by cisplatin, carboplatin and oxaliplatin 131
UCP2, a mitochondrial protein regulated at multiple levels 129
B-cell receptor signaling activity identifies patients with mantle cell lymphoma at higher risk of progression 128
Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine 126
Mitochondrial uncoupling protein-2 inhibition promotes gemcitabine response in cancer cells. 125
Growth delay of human pancreatic cancer cells by methylase inhibitor 5-aza-2'-deoxycytidine treatment is associated with activation of the interferon signalling pathway 124
Mutant p53 and mTOR/PKM2 regulation in cancer cells 122
The antioxidant uncoupling protein 2 stimulates hnRNPA2/B1, GLUT1 and PKM2 expression and sensitizes pancreas cancer cells to glycolysis inhibition 122
Regulation of autophagy by nuclear GAPDH and its aggregates in cancer and neurodegenerative disorders 122
Effects of CD20 antibodies and kinase inhibitors on B-cell receptor signalling and survival of chronic lymphocytic leukaemia cells 122
Onconase Dimerization Through 3D Domain Swapping: Structural Investigations and Increase Of The Apoptotic Effect In Cancer Cells 121
Mutant p53 blocks SESN1/AMPK/PGC-1α/UCP2 axis increasing mitochondrial O2-· production in cancer cells 121
The metabolic landscape of cancer stem cells 120
null 119
UCP2 inhibition induces ROS/Akt/mTOR axis: role of GAPDH nuclear translocation in genipin/everolimus anticancer synergism 118
Trichostatin A enhances the response of chemotherapeutic agents in inhibiting pancreatic cancer cell proliferation. 117
Zinc depletion efficiently inhibits pancreatic cancer cell growth by increasing the ratio of antiproliferative/proliferative genes. 116
The antioxidant mitochondrial protein UCP2 promotes cancer development connecting theWarburg effect and autophagy 115
Oncometabolites in cancer aggressiveness and tumour repopulation 114
Mutant p53-Associated Molecular Mechanisms of ROS Regulation in Cancer Cells 113
Gut microbiota modulates seizure susceptibility 113
Mutant p53 proteins alter cancer cell secretome and tumour microenvironment: involvement in cancer invasion and metastasis 112
Extracellular matrix composition modulates the responsiveness of differentiated and stem pancreatic cancer cells to lipophilic derivate of gemcitabine 112
Targeting survival signaling pathways in chronic lymphocytic leukemia via anti-CD20 antibodies 110
Proteomic analysis of pancreatic ductal carcinoma cells after combined treatment with gemcitabine and trichostatin A 108
Proteomic analysis of pancreatic ductal carcinoma cells treated with 5-aza-2'-deoxycytidine 107
Autocrine mechanisms of cancer chemoresistance 107
Mutant p53 affects the mitochondrial proteome, promoting mitochondrial fragmentation and OXPHOS in pancreatic ductal adenocarcinoma cells 106
Rehabilitation and biomarkers of stroke recovery: study protocol for a randomized controlled trial 106
Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study. 103
Molecular interplay between mutant p53 proteins and autophagy in cancer cells 103
Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumoral activity 99
ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma 98
Mutant p53 induces SIRT3/MnSOD axis to moderate ROS production in melanoma cells 97
3-Bromo-Isoxazoline Derivatives Inhibit GAPDH Enzyme in PDAC Cells Triggering Autophagy and Apoptotic Cell Death 96
CAT rs1001179 Single Nucleotide Polymorphism Identifies an Aggressive Clinical Behavior in Chronic Lymphocytic Leukemia 95
Trichostatin A alters cytoskeleton and energy metabolism of pancreatic adenocarcinoma cells: an in depth proteomic study 95
“Proteomic profiling of pancreatic ductal carcinoma cell lines treated with trichostatin-A” 93
Redox sensitive cysteine residues as crucial regulators of wild-type and mutant p53 isoforms 92
Mitochondrial uncoupling protein 2 and pancreatic cancer: a new potential target therapy 91
Interplay between ROS and Autophagy in Cancer and Aging: From Molecular Mechanisms to Novel Therapeutic Approaches 91
Tumor Suppressor Role of Wild-Type P53-Dependent Secretome and Its Proteomic Identification in PDAC 91
Bone marrow stromal cells up-regulate interleukin 8 production in human T-lymphoblastic leukemia through the CXCL12/CXCR4 axis and the NF-κB and JNK/AP-1 pathways 90
Prolonged exposure to simulated microgravity promotes stemness impairing morphological, metabolic and migratory profile of pancreatic cancer cells: a comprehensive proteomic, lipidomic and transcriptomic analysis 90
Sestrins at the Interface of ROS Control and Autophagy Regulation in Health and Disease 89
Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A. 87
Discovery of a spirocyclic 3-bromo-4,5-dihydroisoxazole covalent inhibitor of hGAPDH with antiproliferative activity against pancreatic cancer cells 85
Regulation of succinate dehydrogenase and role of succinate in cancer 85
MRP5 nitration by NO-releasing gemcitabine encapsulated in liposomes confers sensitivity in chemoresistant pancreatic adenocarcinoma cells 85
The mutant p53-driven secretome has oncogenic functions in pancreatic ductal adenocarcinoma cells 84
Proteomic Signature of PDAC Cells with Mutant p53 83
Mutant p53 prevents GAPDH nuclear translocation in pancreatic cancer cells favoring glycolysis and 2-deoxyglucose sensitivity 82
Roles for microRNA 23b in regulating autophagy and development of pancreatic adenocarcinoma 80
Sex differences in neuromuscular and biological determinants of isometric maximal force 79
Sestrins as a therapeutic bridge between ROS and autophagy in cancer 79
Reprogramming tumor-immune cell interface in solid and hematological malignancies to enhance response to therapy 75
To metabolomics and beyond: a technological portfolio to investigate cancer metabolism 73
miR-125b Upregulates miR-34a and Sequentially Activates Stress Adaption and Cell Death Mechanisms in Multiple Myeloma 73
The cancer secretome and secreted biomarkers 70
From single gene analysis to single cell profiling: a new era for precision medicine 67
Morphologic Characterization of Pancreatic Ductal Adenocarcinoma following Post-neoadjuvant Pancreatectomy and Clinical value of Intratumor Heterogeneity 66
Hypoxia dictates metabolic rewiring of tumors: implications for chemoresistance 66
Totale 12.441
Categoria #
all - tutte 47.485
article - articoli 43.686
book - libri 0
conference - conferenze 3.799
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.970


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021539 0 0 0 0 103 90 33 49 45 10 106 103
2021/2022815 114 200 20 53 21 19 26 52 25 29 71 185
2022/20231.867 121 196 154 364 158 418 23 98 206 61 50 18
2023/2024940 37 56 74 92 116 217 29 78 15 48 132 46
2024/20252.431 112 153 90 398 129 74 113 142 411 159 206 444
2025/20263.180 559 532 672 1.267 150 0 0 0 0 0 0 0
Totale 13.024